Guru Fundamental Report for HIMS

Validea's guru fundamental report indicates that HIMS & HERS HEALTH INC (HIMS) receives a 75% rating based on their Small-Cap Growth Investor model, which is based on the Motley Fool strategy, highlighting the firm's solid fundamentals and strong price performance; key strengths include profit margin, relative strength, sales and EPS growth, and insider holdings, while weaknesses include cash and cash equivalents, the 'Fool Ratio', average shares outstanding, and sales.

Analysis

HIMS & HERS HEALTH INC (HIMS) has been assigned a 75% rating by Validea's Small-Cap Growth Investor model, which is derived from the Motley Fool's published strategy. This score suggests a moderate alignment with the model's criteria for small-cap growth stocks that exhibit solid fundamentals and strong price performance, though it remains below the 80% threshold that typically signals initial interest from the strategy. The company successfully meets several fundamental criteria, including those for Profit Margin, Relative Strength, year-over-year comparison of Sales and EPS Growth, Insider Holdings, Cash Flow from Operations, Profit Margin Consistency, R&D as a percentage of Sales, Inventory to Sales, Accounts Receivable to Sales, Long Term Debt/Equity Ratio, and Price. Conversely, HIMS fails to meet the model's standards for Cash and Cash Equivalents, "The Fool Ratio" (P/E to Growth), Average Shares Outstanding, absolute Sales levels, Daily Dollar Volume, and Income Tax Percentage. It is noteworthy that the report classifies HIMS as a "large-cap growth stock," yet it is being evaluated using a "Small-Cap Growth Investor model," a discrepancy that could affect the interpretation of certain failed metrics, particularly those related to company size, liquidity, and valuation expectations.

Key Decisions for Investors

• Investors should acknowledge HIMS's positive fundamental attributes, such as its strong profit margins, relative price strength, and successful performance on several growth and operational efficiency metrics as per the Validea model.
• Careful consideration is warranted for the failed criteria, specifically concerning cash and cash equivalents, the P/E to growth ('Fool Ratio') valuation, average shares outstanding, absolute sales levels, and daily dollar volume, as these may indicate potential financial vulnerabilities or overvaluation.
• Further due diligence is advised to assess the implications of applying a small-cap focused model to a company described as large-cap, and to determine how the noted weaknesses, especially in valuation and liquidity, align with individual risk profiles and investment strategies.